Abstract:Posttraumatic stress disorder (PTSD) is common, with a lifetime prevalence of approximately 6%. PTSD may develop at least one month after a traumatic event involving the threat of death or harm to physical integrity, although earlier symptoms may represent an acute stress disorder. Symptoms typically involve trauma-related intrusive thoughts, avoidant behaviors, negative alterations of cognition or mood, and changes in arousal and reactivity. Assessing for past trauma in patients with anxiety or other psychiatric illnesses may aid in diagnosing and treating PTSD. The Diagnostic and Statistical Manual of Mental Disorders, 5th ed., text revision provides diagnostic criteria, and the PTSD Checklist for DSM-5 uses these diagnostic criteria to help physicians diagnose PTSD and determine severity. First-line treatment of PTSD involves psychotherapy, such as trauma-focused cognitive behavior therapy. Pharmacotherapy is useful for patients who have residual symptoms after psychotherapy or are unable or unwilling to access psychotherapy. Selective serotonin reuptake inhibitors (i.e., fluoxetine, paroxetine, and sertraline) and the serotonin-norepinephrine reuptake inhibitor venlafaxine effectively treat primary PTSD symptoms. The addition of other pharmacotherapy, such as atypical antipsychotics or topiramate, may be helpful for residual symptoms. Patients with PTSD often have sleep disturbance related to hyperarousal or nightmares. Prazosin is effective for the treatment of PTSD-related sleep disturbance. Clinicians should consider testing patients with PTSD for obstructive sleep apnea because many patients with PTSD-related sleep disturbance have this condition. Psychiatric comorbidities, particularly mood disorders and substance use, are common in PTSD and are best treated concurrently.

Posttraumatic Stress Disorder in the DSM-5: Controversy, Change, and Conceptual Considerations

Testing the DSM-5 New Items and Algorithm Change for the Diagnosis of Posttraumatic Stress Disorder

Latest developments in post-traumatic stress disorder: diagnosis and treatment

The Etiology and Pathogenesis of Post-Traumatic Stress Disorder

Post‐traumatic stress disorder: a state‐of‐the‐art review of evidence and challenges

A paradigm shift in the conceptualization of psychological trauma in the 20th century

Psychometric Properties of the Posttraumatic Stress Disorder Symptom Scale Interview for Dsm-5 (Pssi-5)

Psychometric Properties of the Posttraumatic Diagnostic Scale for DSM-5 (PDS-5).

Posttraumatic stress disorder (PTSD) in a sample of patients evaluated for acute coronary syndrome: A factor analysis of the PTSD checklist for DSM-5 (PCL-5)

Cognitive Emotion Regulation Strategies Associated with the DSM-5 Posttraumatic Stress Disorder Criteria.

Posttraumatic Stress Disorder in Adults: Impact, Comorbidity, Risk Factors, and Treatment

Posttraumatic Stress Disorder: Evaluation and Treatment

Controversies in trauma- and stress-related disorders

Posttraumatic Stress Disorder in the Primary Care Setting: Summary of Recommended Care

Neurobiology and Treatment of Posttraumatic Stress Disorder

The epidemiology of DSM-5 posttraumatic stress disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III

ADHD in the DSM-5-TR: What has changed and what has not

Post-traumatic stress disorder: a psychiatric disorder requiring urgent attention.

Prevalence and concordance of International Classification of Diseases-11th Revision and Diagnostic and Statistical Manual-Fifth Edition posttraumatic stress diagnostics among Northern Irish military veterans.

Post-traumatic stress disorder in disaster survivors

The revised Clinician‐Administered PTSD scale for DSM‐5 (CAPS‐5‐R): Initial psychometric evaluation in a trauma‐exposed community sample